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Many developed countries, like Australia, maintain a high population level immunity against measles,
however, there remains a risk of acquisition of measles in non-immune travellers and subsequent impor-
tation into Australia leading to localised outbreaks. In this study, we estimate the incidence of measles
and describe characteristics including immunisation and pre-travel health seeking behaviour of notified
cases of measles in New South Wales and Victoria, Australia between February 2013 and January 2014.
Cases were followed up by telephone interview using a questionnaire to collect information of demo-
graphic and travel characteristics. In NSW, the incidence was highest in age group 0–9 years (20/million
population) whereas in Victoria the highest incidence was observed in 10–19 (23/million population)
years group. Out of 44 cases interviewed, 25 (56.8%) had history of travel outside of Australia during
or immediately prior to the onset of measles. Holiday (60%) was the main reason for travel with 44%
(11/25) reporting visiting friends and relatives (VFR) during the trip. The major reason described for
not seeking prior medical advice before travel were ‘‘no perceived risk of diseases” (41%) and ‘‘previous
overseas travel without any problem” (41%). Of the 25 measles cases with recent overseas travel during
the incubation period, one reported a measles vaccine prior to their recent trip. Four cases were children
of parents who refused vaccination. Twenty out of 25 (80.0%) had attended mass gathering events. Young
adults and VFR travellers should be a high priority for preventive strategies in order to maintain measles
elimination status.
 2016 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Measles is a highly infectious viral infection which can result in
severe complications such as pneumonia, encephalitis and death
[1]. The World Health Organization (WHO) considers measles a
global challenge and has set a goal for measles elimination in five
WHO regions by 2020 [2]. Many developed countries, like Aus-
tralia, maintain a high population level immunity against measles
(>90% in all age groups) which is required to interrupt endemic
transmission [3,4], however, there remains a risk of acquisition of
measles in non-immune travellers and subsequent importation
into Australia.
In March 2014, WHO declared that measles elimination has
been achieved in Australia [5]. Although endemic transmission of
measles has been eliminated from Australia, considerable numbers
of cases are imported each year via international travel. The trans-
mission by imported cases can lead to localised outbreaks with
ongoing transmission particularly in communities and geographi-cal regions where the population-level immunity is low [6].
Measles outbreaks occur regularly in Australia as a result of impor-
tation. In 2012, the largest outbreak of measles in Australia since
1997 occurred primarily in Southwest Sydney resulting in 167
cases which were linked to an imported case from Thailand [7].
Under-vaccinated groups including migrants were identified as
key risk groups driving the ongoing transmission. Approximately
20% of cases were in people of Pacific Islander descent and many
cases were in Australian residents who had not travelled, particu-
larly those who were too young to be vaccinated [7].
Measles is endemic in many countries of South and Southeast
Asia which are popular travel destinations for Australian residents.
For example, the Philippines had almost 60,000 cases of measles
during 2011–2014, with a surge in cases following Typhoon Haiyan
[8]. In 2014, a total of 53,803, 7928, 7580, and 834 confirmed cases
of measles were reported to the WHO by the Philippines, Indone-
sia, Vietnam, and Thailand respectively [9]. Importation of cases
and recurrent outbreaks continue to test the status of measles
elimination in Australia and other developed countries For exam-
ple in 2015, a large epidemic of 147 cases occurred in visitors to
Disneyland, California, USA and their contacts resulting in
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[10]. Measles control is challenging because it has a very high
reproductive number, estimated to be between 11 and 18, and
requires high vaccination coverage (in excess of 93%) to achieve
herd immunity and maintain elimination [11]. Currently two doses
of measles-containing vaccine are recommended for all children in
Australia with the first dose recommended at 12 months and sec-
ond at 18 months [12]. Measles is a nationally notifiable disease
in Australia.
The number of Australian residents departing for short term
trips abroad in 2014–2015 was 9.2 million, almost double com-
pared to 2004–2005 [13]. The highest volume destination coun-
tries in 2015 included Indonesia (Bali), Thailand, India, and
China, which have substantial measles circulation [13,14]. A signif-
icant proportion (27%) of departing residents report visiting friends
and relatives (VFRs) as their purpose of travel [13]. Travellers from
developed countries travelling to their country of origin or their
parent’s country of origin in a less developed country are at dispro-
portionate risk of acquiring infectious diseases compared to other
travellers, due to increased exposure and lower rates of pre-
travel health seeking behaviours, including vaccination [15,16].
The control of measles in the elimination phase in Australia neces-
sarily must focus on the populations at risk of under-vaccination,
particularly geographical areas with low population immunity,
with targeted strategies for achieving higher vaccination rates in
these groups. Understanding the epidemiology of measles cases
in Australia will assist in targeting strategies for measles control.
In this report, we describe characteristics including immunisation
and pre-travel health seeking behaviour of notified cases of
measles in New South Wales and Victoria between February
2013 and January 2014.0
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Fig. 1. Reported studies of measles outbreak in Australia. Note: Each circle
represents an outbreak of Measles in Australia. The size of the circle is proportional
to the size of the outbreak but not exactly to scale.2. Methods
Measles is a notifiable disease in Australia. Confirmed cases of
measles notified to Departments of Health in New South Wales
and Victoria from February 2013 to January 2014 were identified.
During routine follow-up of notified cases, public health officers
obtained permission from the case, or case’s parent/guardian, to
be contacted by the research team by telephone to administer an
enhanced surveillance questionnaire. Among a total of 106 notified
cases of measles, 79 (74.5%) agreed to be contacted by the
researchers. Verbal informed consent was obtained from partici-
pants by researchers prior to administering the telephone ques-
tionnaire. The study included the participants only if they had
either acquired measles in Australia or from travel departing from
Australia (overseas visitors and arriving migrants were excluded
from the survey).
The questionnaire collected demographic details including
migrant status; travel history including international travel within
the incubation period, itinerary, reason for travel and length of
stay, accommodation; whether travel-associated cases had sought
pre-travel health advice from a healthcare provider or non-medical
sources, had received a MMR vaccine prior to travel and under-
taken disease-specific at-risk behaviours during travel such as
attending mass gatherings during travel. Mass gatherings were
defined as organised group events, with examples given (such as
concerts, religious pilgrimages, and sporting events).
Distributions of variables are presented as percentages.
Age-specific incidence rates of measles in NSW and Victoria are
calculated using the age-wise populations projected for 2013 for
NSW and Victoria obtained from the Australian Bureau of Statistics
[17]. Patients/carers perspectives on possible transmission source,
reasons for not vaccinating, reasons for not seeking medical advice
prior to travel are presented for those who acquired measlesduring travel. This study was approved by the NSW Population &
Health Services Research Ethics Committee (2012/04/382).
A systematic review of literature was also conducted to identify
studies reporting the outbreaks of measles in Australia from 2000
to 2012 using ‘‘PubMed”, ‘‘Google scholar” and online websites of
medical journals published from Australia using the terms ‘‘out-
break” and ‘‘measles”. Studies and reports that reported the num-
ber of cases, place and date of outbreak were included to create a
timeline of measles outbreaks in Australia.
3. Results
Fig. 1 shows the chronology of reported outbreaks of measles
from 2000 to 2012. A total of 106 measles cases were notified in
NSW (N = 43) and Victoria (N = 63) during the study period. Age-
specific incidence rates of measles in NSW and Victoria are pre-
sented in Fig. 2. In NSW, the incidence was highest in age group
0–9 years (20/million population) whereas in Victoria the highest
incidence was observed in 10–19 (23/million population) years
group. There were three cases which were <12 months of age when
they departed for travel, but only 1 was >9 months for whom pre-
travel measles vaccine could have been recommended. Fig. 3
shows the timeline of notification of measles in each state per
month, with 71% of notifications occurring between August 2013
and January 2014. Of those 106 cases, contact details were avail-
able for 79 cases. Among those 79, 11 were unable to be contacted
for interview, 13 did not consent to be contacted, 3 were overseas
visitors (since departed overseas) and 1 was an arriving migrant.
Overall, 44 out of 106 (41.5%) completed the interview. Demo-
graphic details of included measles cases are presented in Table 1
including information on age, sex, Australian citizenship/residence
status, region of birth, immigration history, language other than
English spoken at home, and education.
Out of 44 cases, 25 (56.8%) had history of travel outside of Aus-
tralia during or immediately prior to the onset of measles and were
part of enhanced surveillance. Holiday (60%) was the main reason
for travel with 44% (11/25) reporting visiting friends and relatives
(VFR) during the trip. Of those participating in the enhanced
surveillance, 52% had a trip length of 2 weeks to 1 month. Of the
VFR travellers, 6 had travelled to the Philippines. In terms of past
travel, 17/25 (78%) had travelled overseas from Australia 1–5
times, and 25% travelled >5 times in last 5 years. Twenty out of
25 (80%) participants were either migrants or had migrant parents.
Most travel bookings were made directly on the Internet by the
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Fig. 2. Age-specific incidence of measles in Victoria and New South Wales in
2013–2014 (total reported cases (N) = 106).
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Fig. 3. Timeline of measles notifications in NSW and Victoria 2013–2014 (total
reported cases (N) = 106).
Table 1
Demographics of participants completing the survey (N = 44).
Demographics N (%)
International travel
Yes 25 (56.8%)
No 19 (43.2%)
Age
0–9 years 14 (31.8)
10–19 years 9 (20.5)
20–29 years 7 (15.9)
30–39 years 9 (20.5)
40–49 years 4 (9.1)
50–59 years 1 (2.3)
Sex (Male) 28 (63.6)
Australian Citizen/PR
Australian Citizen/PR 43 (97.7)
International Student 1 (2.3)
Region of birth
Australia 31 (70.5)
South-East Asia 7 (15.9)
Middle East 1 (2.3)
Pacific (including New Zealand) 1 (2.3)
Europe 4 (9.1)
Migrant status of cases
Australian born, Australian born parents 17 (38.6)
Australian born, migrant parents 14 (31.8)
Migrant, Migrant parents 13 (29.5)
Speaks a language other than English 17 (38.6)
Education
Postgraduate Degree 1 (2.7)
Bachelor’s Degree 9 (20.4)
Trade certificate 6 (13.6)
Secondary School 10 (22.7)
Primary School 2 (4.6)
Some Primary School 3 (6.8)
State
New South Wales 20 (45.5)
Victoria 24 (55.5)
Migrant years (mean) 14.1 (sd, 10.00)
Notes: N = number in each category, PR, permanent resident, sd, standard deviation.
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six per cent of travel bookings were made within 3 months prior to
the date of travel (Table 2). Table 2 shows the countries travelled
by imported cases, with 21/25 (84%) travelling to countries in Asia,
with Thailand 6/21 (24%) and the Philippines 6/21 (24%) being the
most common destinations.
3.1. Travel health seeking behaviour
Only one participant sought pre-travel medical advice from
their regular GP, whereas three had sought non-medical pre-
travel advice, with all reporting advice from a friend or relative
and one also reporting Internet sources. The major reason
described for not seeking prior medical advice before travel were
‘‘no perceived risk of diseases” (41%) and ‘‘previous overseas travel
without any problem” (41%) (Table 3).
3.2. Vaccination history
A history of at least one dose of measles-containing vaccine was
reported by 7 participants; 4 reported having received at least two
doses of vaccine, two aged 20 and 30 years, reported only one dose
of vaccine, and one reported a single dose of vaccine as pre-travel
vaccine. 3 cases were too young to be vaccinated (<12 months). 2reported that they possibly had MMR in childhood, but were
unsure. 3 mothers mentioned that ‘they do not vaccinate their kids’
resulting in 4 cases in their children. No information was available
regarding vaccination in 9 cases.3.3. Measles contact and possible source
Of imported cases, 4/25 reported possible contact with an infec-
tious person (hospital = 1, flight = 1, friend with measles = 1, recre-
ational setting = 1) and 19/25 (80.0%) had attended mass gathering
events in the destination country. The reported mass gathering
included range of events such as Christmas parties, fireworks for
New Year’s Eve, a funeral, a night club, a wedding, group prayers,
community markets, music festivals, and theme parks.4. Discussion
Importation of measles is a continuing threat to disease control
in Australia and other developed countries which have achieved
measles elimination. Local transmission of imported cases can be
minimised by identifying groups at risk of under-vaccination and
introducing measures to increase vaccination coverage in these
vulnerable groups. This may include targeted catch-up campaigns
or processes to improve pre-travel health seeking behaviours and
vaccination in travellers. This could lead to significant savings of
Table 2
Distribution of travel characteristics in measles cases (N = 25).
Variable N (%)
aTrip length (range: 7–730 days) 51.7 (sd, 143)
Trip length (categories)
1 to <2 weeks 7 (28.0)
2 weeks to <1 month 13 (52.0)
1 to <2 months 2 (8.0)
2 to <3 months 1 (4.0)
3+ months 2 (8.0)
Countries travelled
Philippines 6 (24.0)
Thailand 6 (24.0)
Indonesia 5 (20.0)
India 3 (12.0)
Singapore 2 (8.0)
Croatia 1 (4.0)
New Zealand 1 (4.0)
Saudi Arabia 1 (4.0)
United Kingdom 1 (4.0)
Trip booking method
Internet 14 (56.0)
Travel agent 7 (28.0)
Other 4 (16.0)
Booking length prior to trip
<1 month 5 (20.0)
1–3 months 14 (56.0)
>3 months 6 (24.0)
Percentage of VFRs using travel agent 4 (36.0)
Travel frequency in last 5 years
0 2 (8.0)
1–2 10 (40.0)
3–5 7 (28.0)
>5 6 (24.0)
Note: sd, standard deviation.
a Trip length is expressed as mean and sd.
b Can be greater than VFR ‘yes’, because multiple responses were allowed.
Table 3
Travel health seeking behaviour (N = 25).
Variable N (%)
Travel frequency in last 5 years
0 2 (8.0)
1–2 10 (40.0)
3–5 7 (28.0)
>5 6 (24.0)
Pretravel advice
No 24 (96.0)
Yes 1 (4.0)
Non-medical Pretravel advice
No 22 (88.0)
Yes 3 (12.0)
Reasons not seeking medical advice
No perceived risk of diseases 9 (40.9)
Travelled overseas previously and had not become unwell 5 (22.7)
Previous travel to country of origin with no problems 4 (18.2)
Thought already fully vaccinated 2 (9.1)
Others 2 (9.1)
Possible contact with person with fever and rash 4 (16.0)
Attended events of mass gathering 20 (80.0)
C.R. MacIntyre et al. / Vaccine 34 (2016) 4386–4391 4389disease associated costs as well as resources for investigation and
control of potential outbreaks.
We found a variation in the ages of notified cases between Vic-
toria and NSW, with a higher proportion of older children and
teenagers in the former. A previous serosurvey suggests that chil-
dren and young adults in Victoria have lower seropositivity for
measles IgG compared to older age groups and other states except
the Northern Territory [3], although recent data in Australia, sug-
gest 93.3% MMR vaccination coverage in children by 60 months
of age [18]. Outbreaks of measles in school and university students
continue to occur in Victoria [19]. A considerable proportion of
younger adults travel and contract the disease in endemic coun-
tries [20]. The Australian practice of ‘‘schoolies”, or group holidays
of teenagers to Asia, at the completion of high school, is a consid-
erable risk for measles exposure, and an awareness campaign was
conducted in Victoria to raise vaccination rates in older teenagers
embarking on ‘‘schoolies”. Over half of notified cases occurred in
individuals <20 years old, including 3 infant too young to be vacci-
nated, highlighting the vulnerability of young people and children
to measles. In addition, 38.6% of cases were in family who speak
language other than English at home, access and utilisation of
health services including preventive programs is shown to be
lower in such population [21]. There were also four children who
were not vaccinated because their parents objected to vaccination,
identifying this as an important source of risk for measles out-
breaks. Australia has recently introduced a ‘‘No Jab, No Pay” policy
which links financial incentives for parents with vaccination, and
does not allow conscientious objection (whereas previously objec-
tors were eligible for financial incentives). Preliminary reports sug-
gest vaccination rates have improved since then [22].In the 2015 meeting of the WHO Regional Verification Commis-
sion (RVC) for Measles Elimination, in the Western Pacific the RVC
recommended consideration of a national plan to address the
emerging immunity gap in teenagers and young adults in Australia
as a means of maintaining Australia’s measles elimination status
[23]. The policy response to epidemics of measles in countries such
as Australia and the USA has included mandating infant and child-
hood vaccination and removal of philosophical exemptions [24,25].
Coercive policies risk a backlash, pushing hesitant parents firmly
into the vaccine refuser group, when other countries such as
Canada have achieved high coverage rates without any mandate
[25,26]. The No Jab, no pay legislation in Australia targets infants,
who are not the age group at highest risk of measles under-
vaccination [25]. Whilst in the USA, under-vaccinated infants were
identified as one of several risk groups contributing to the Disney-
land outbreak [26], travel or exposure to infectious visitors or
returned travelers is a ubiquitous risk factor in this and other out-
breaks. Whilst infants and young children are the largest risk group
for secondary acquisition of measles in Australia, adolescents and
young adults are more likely to be under-vaccinated and are the
largest group of notified travel-associate cases, as shown in our
study. Young adults comprise the 65–75% of travel-acquired cases
notified in Australia [27]. As such, strategies for catch-up vaccina-
tion for this risk group should be considered, with pre-travel con-
sultations with primary care providers and travel clinics important
access points. Currently there is no systematic means of identifying
travellers for preventive health measures, and the trend to increas-
ing booking of flights online makes this a challenge. More wide-
spread health promotion may be required.
Migrants and VFR travellers (many of whomwere young adults)
were a major risk group in our study, with 80% of the notified
measles cases migrants or Australian-born with migrant parents.
Of the travel-associated cases, almost half were VFR travellers,
and 6 of them had travelled to the Philippines after typhoon Hai-
yan in 2013, which was followed by a major epidemic of measles
[28]. VFRs returning from countries with recent natural disasters
or humanitarian emergencies may be at greater risk of importing
diseases such as measles. The volume of travel between Australia
and New Zealand, and role of people moving between the two
countries in the 2012 epidemic in Sydney [7] suggests this could
also be a focus of targeted prevention, however in our study we
observed only a single case of measles related to travel to New
4390 C.R. MacIntyre et al. / Vaccine 34 (2016) 4386–4391Zealand. Children of migrants are at risk of under-vaccination – in a
large outbreak affecting 168 children in Sydney, only 40 (24%) had
reported at least one dose of MMR [7]. This represents another
focus for catch up vaccination campaigns.
Almost 80% of travellers had travelled multiple times in the past
5 years, but only one had sought medical advice before travel. The
majority did not perceive any risk of acquiring diseases such as
measles. Low risk perception is a major barrier to seeking pre-
travel health advice from a health professional, particularly for
VFR travellers [29,30]. Best practice for a pre-travel medical con-
sultation includes ensuring travellers are up to date with routine
vaccination. In this study, only one person who contracted measles
reported pre-travel vaccination for measles. In this case, although
self-reported vaccination status may be unreliable, we cannot rule
out vaccine failure. The majority of cases were unable to report
their vaccination status or incorrectly considered themselves pro-
tected against measles, highlighting the importance of a whole of
life vaccine register, to reliably identify people in need of catch
up vaccination. In an Australian university student study
(n = 1663); 20.9% of young people reported prior measles vaccina-
tion; 51% were unaware of their measles vaccination status; and
students had a low perception of risk and likelihood of infection
during travel [31]. In a study of Australian travellers, only 1.6%
reported a pre-travel MMR vaccine [29]. Studies assessing knowl-
edge, attitudes and practices of travellers show low awareness of
travel vaccination in general and few studies have examined
measles specifically. Young adults travelling to measles endemic
regions, especially those who are of migrant background, should
be appropriately educated about measles and offered vaccination
if vaccination status is unknown. Educating travellers about poten-
tial risk of infectious diseases acquired during travel and preven-
tion strategies through appropriate pre-travel medical advice is
important for disease prevention among travellers. In addition,
travellers attending mass gathering events in closed spaces may
be at greater risk of contracting diseases such as measles and trav-
ellers should be made aware of the risk and encouraged to seek
appropriate prevention measures.
The study has several limitations. This study relied on self-
report of behaviours and vaccination status, and responses were
not validated. Therefore recall bias may affect vaccination history
as well as health seeking behaviours. The study only examined
notified measles cases in two states, NSW and Victoria with
enhanced surveillance of 41% of cases during this period. However,
these are the two most populous states of Australia.
Analysis of notified cases of measles confirms the role of travel
in measles epidemics, with over half of cases having a history of
international travel. Half did not have a history of travel, but were
likely exposed to an infectious traveller or were part of a chain of
transmission that started with a traveller Age specific patterns vary
somewhat between jurisdictions, but children, teenagers and
young adults remain most at risk, being important groups for catch
up vaccination. In NSW, school-based catch up campaigns have
commenced, addressing this risk. Year 11 and 12 students without
a record of two doses of measles-containing vaccine have been
offered a free dose of MMR vaccine at high school since 2014
[29]. Similar strategies should be considered in other jurisdictions.
In addition all people born after 1966 who have not had 2 doses of
vaccine are at risk of measles and should be considered for catch
up vaccination [12].
As a consequence of increased and rapid global mobility, effec-
tive control of infectious disease requires both local and global
solutions. MMR vaccination of travellers, including VFR travellers,
should play an important role in Australia’s disease control efforts.
Key opportunities for the maintenance of measles elimination in
Australia include improved awareness of the need to vaccinate
pre-travel, particularly a young adult vaccination strategy. A newwhole-of-life Australian immunisation register was announced in
2015 [32], and will improve the ability to identify people who
require catch up vaccination, and should ideally capture data on
country of birth to ensure maximal benefit of the register. Expan-
sion of national notification data to include details of travel itiner-
ary, reason for travel in addition to ethnicity will enhance
surveillance efforts. As long as measles remains endemic in many
countries globally, the risk of measles epidemics will continue in
Australia and other countries which have achieved measles elimi-
nation. Global efforts for measles control must focus on countries
with the highest burden of disease, whilst countries such as Aus-
tralia which have achieved elimination, must continue efforts to
protect elimination status. A recent modelling study predicted sub-
stantial risk of measles epidemics in NSW, Victoria and Queens-
land, with areas of predicted risk corresponding with observed
outbreaks [33]. This same study shows in one scenario that
measles elimination may be threatened, with R being above 1
(and hence creating epidemic conditions) in Australia. Recent evi-
dence about waning of measles vaccine-induced immunity (previ-
ously thought to be life-long) is also a factor to be considered [34],
as waning immunity may also threaten elimination status.
Since the 1998 measles control campaign in Australia, the pro-
portion of the population with vaccine-induced immunity has
grown, and older vaccinated cohorts may becomemore susceptible
to measles over time. Against this backdrop, measles will continue
to be introduced through travel into countries such as Australia
which have achieved elimination status. In 2015–16, Australia
has had multiple outbreaks in several jurisdictions, which high-
lights the ongoing risk. Young adults and migrants should be a high
priority for preventive strategies in order to maintain measles
elimination status.Funding
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